S100A10-ANXA2 tetramer inhibition hampers hepatic stellate cell activation in human MASLD organoids
Miranda Türkal, Christine Maeder, Marta Correia de Sousa, Margot Fournier, Sanae El-Harane, Monika Gjorgjieva, Michelangelo Foti, Pierre Maechler, Etienne Delangre · 2026
Read S100A10-ANXA2 tetramer inhibition hampers hepatic stellate cell activation in human MASLD organoids by Miranda Türkal, Christine Maeder, Marta Correia de Sousa, Margot Fournier, Sanae El-Harane, Monika Gjorgjieva, Michelangelo Foti, Pierre Maechler, Etienne Delangre (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13365249.txt.
Description
Miranda Türkal and co-workers test in 2026 a block on a two part cell protein pair as a cure path for fatty liver scar. Fatty liver can move to swell and scar, and scar sets death risk. The pair helps wake scar cells in the liver, the team held.
A drug that breaks the pair cut wake marks and scar genes in lab liver scar cells. In lab grown mini livers with the ill, it cut scar and glue lay down, with no shift in fat load. The block works through a route clear of the main scar path. A new aim stands out.
Catalog record
| CREATOR | Miranda Türkal, Christine Maeder, Marta Correia de Sousa, Margot Fournier, Sanae El-Harane, Monika Gjorgjieva, Michelangelo Foti, Pierre Maechler, Etienne Delangre |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 104908 |
| LICENSE | https://creativecommons.org/publicdomain/zero/1.0 |
| RIGHTS | CC0 |
| SOURCE | Europe PMC |